Effect of organometals on cardiac, platelet and vascular prostaglandin biosynthesis
Ally, A.I.
Progress in Clinical and Biological Research 242: 177-183
1987
ISSN/ISBN: 0361-7742 PMID: 3118381 Document Number: 287306
Document emailed within 1 workday
Related Documents
Babadzhanova, D.D.; Koshel', I.V.; Markov, K.M.; Zadkova, G.F.; Pinelis, V.G. 1987: Platelet aggregation and biosynthesis of prostaglandin in thrombocytes in children with chronic idiopathic thrombocytopenic purpura Pediatriia 8: 43-45De Clerck, F.; Vermylen, J.; Reneman, R. 1975: Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. in vitro experiments Archives Internationales de Pharmacodynamie et de Therapie 216(2): 263-279
Wilson, W.R.; Greenberg, S.; Kadowitz, P.J.; Diecke, F.P.; Long, J.P. 1975: Interaction of prostaglandin A2 and prostaglandin B2 on vascular smooth muscle tone, vascular reactivity and electrolyte transport Journal of Pharmacology and Experimental Therapeutics 195(3): 567-576
Kriska, M.; Kovalcík, V. 1979: Analysis of the effect of some inhibitors of prostaglandin biosynthesis upon neonatal vessels Bratislavske Lekarske Listy 71(4): 460-469
Rolland, P.H.; Martin, P.M.; Rolland, A.M.; Bourry, M.; Serment, H. 1979: Benign breast disease: studies of prostaglandin E2, steroids, and thermographic effects of inhibitors of prostaglandin biosynthesis Obstetrics and Gynecology 54(6): 715-718
Barradas, M.A.; Stansby, G.; Hamilton, G.; Mikhailidis, D.P. 1994: Diminished platelet yield and enhanced platelet aggregability in platelet-rich plasma of peripheral vascular disease patients International Angiology: a Journal of the International Union of Angiology 13(3): 202-207
Kato, H.; Takashima, T.; Kishikawa, H.; Emura, S.; Ohmori, K. 1996: Effect of beraprost sodium, a stable prostaglandin I2 analogue, on platelet aggregation in diabetes mellitus International Journal of Clinical Pharmacology Research 16(4-5): 99-102
Yano, T. 1990: Effect of prostaglandin family on peripheral vascular system Nihon Rinsho. Japanese Journal of Clinical Medicine 48(6): 1143-1147
Tavella, J.M.; Tournier, H.; Schinella, G.; de Bravo, M.G.; De Tomás, M.E.; Mercuri, O. 1988: Changes in the plasma free fatty acid composition during VLDL lipolysis induced by heparin: their effect on platelet phosphatidylcholine biosynthesis Biomedica Biochimica Acta 47(8): 725-730
Fiedel, B.A.; Simpson, R.M.; Gewurz, H. 1977: Effects of C-reactive protein on platelet function. III. the role of cAMP, contractile elements, and prostaglandin metabolism in CRP-induced inhibition of platelet aggregation and secretion Journal of Immunology 119(3): 877-882
Holmsen, H. 1977: Prostaglandin endoperoxide--thromboxane synthesis and dense granule secretion as positive feedback loops in the propagation of platelet responses during "the basic platelet reaction" Thrombosis and Haemostasis 38(4): 1030-1041
Bamba, H.; Ota, S.; Kato, A.; Kawamoto, C.; Matsuzaki, F. 2000: Effect of prostaglandin E1 on vascular endothelial growth factor production by human macrophages and colon cancer cells Journal of Experimental and Clinical Cancer Research: Cr 19(2): 219-223
Fukuoka, T.; Nakajima, Y.; Matsumoto, M.; Nakano, H.; Shiratori, T. 1988: Effect of a platelet activating factor (PAF) antagonist on the hepatic afferent vascular occlusion Nihon Geka Gakkai Zasshi 89(5): 788
Berger, D.I.; Pilipchuk, D.B.; Sapozhkov, A.V.; Freĭmanis, I.F. 1989: Effect of synthetic prostaglandin E1 on the cardiac blood supply and systemic hemodynamics in acute myocardial ischemia Farmakologiia i Toksikologiia 52(1): 30-33
Janssens, W.J.; Cools, F.J.; Hoskens, L.A.; Van Nueten, J.M. 1990: Effect of ridogrel on vascular contractions caused by vasoactive substances released during platelet activation Thrombosis and Haemostasis 64(1): 91-96
Stinger, R.B.; Fitzpatrick, T.M.; Corey, E.J.; Ramwell, P.W.; Rose, J.C.; Kot, P.A. 1982: Selective antagonism of prostaglandin F2 alpha-mediated vascular responses by N-dimethylamino substitution of prostaglandin F2 alpha Journal of Pharmacology and Experimental Therapeutics 220(3): 521-525
Takasaki, K.; Noguchi, Y.; Ogawa, K.; Hirato, K.; Saito, H.; Yanaihara, T.; Nakayama, T. 1987: Biosynthesis of prostaglandin in human cervical tissue Nihon Sanka Fujinka Gakkai Zasshi 39(9): 1565-1570
Tsuji, T. 1986: Study on therapy with prostaglandins in choroidal vascular disorders. I. Effect of prostaglandin I2 on choroidal circulation Nippon Ganka Gakkai Zasshi 90(10): 1289-1294
Deby, C.; Descamps, M.; Binon, F.; Bacq, Z.M. 1971: In vitro inhibition of the biosynthesis of e 2 prostaglandin by anti-inflammatory drugs Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 165(12): 2465-2468
Conte, D.; Romanelli, F.; Nordio, M.; Baldacci, M.; Isidori, A. 1985: Effects of the "vascular factor" on platelet and vascular arachidonic acid metabolism in man International Journal of Clinical Pharmacology Therapy and Toxicology 23(11): 601-603